Korean Multicenter Randomized Controlled Trial (RCT) of Pidogul for Patients With Coronary Stenting
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 148 participants.
Also called NCT01584791
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 148 participants
- Registry
-
NCT01584791
-
- Other papers using this trial's data
- Comparison of antiplatelet efficacy and tolerability of clopidogrel napadisilate with clopidogrel bisulfate in coronary artery disease patients after percutaneous coronary intervention: a prospective, multicenter, randomized, open-label, phase IV, noninferiority trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- Not reported
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01584791. Randomized; no masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2012-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Korean Multicenter Randomized Controlled Trial (RCT) of Pidogul for Patients With Coronary Stenting
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- clopidogrel napadisilate + aspirin
- Intervention (Drug)
- clopidogrel bisulfate + aspirin
- Lead sponsor
- Seoul National University Hospital
- Collaborator
- Hanmi Pharmaceutical co., ltd.
Record details
- Record id
cardio:ct-nct01584791- Content hash
73ac54aed1296bcb4e4661868864cef14423fa1c144baf692ddea43d5528d327